What You Should Know:
– PathAI, a global leader in AI-powered pathology, unveiled two novel AI products, PathExplore™ Immuno-Oncology Profiling (IOP) and IHC Explore1™ to empower cancer drug developers and clinical researchers with AI-powered insights.
– …
Continue Reading
Here’s part 2 of MedCity News’ Q&A with Astellas Pharma CEO Naoki Okamura who was in South San Francisco last week for the opening of the Japanese pharma company’s West Coast Innovation Center. You…
Continue Reading
A new company emerged out of stealth mode this week at the SynBioBeta conference in San Jose. The startup, called CybergenX, is seeking to integrate AI-powered cybergenetic technology into the synthetic biology field.
The company,…
Continue Reading
Last month, an app named Rejoyn became the first FDA-cleared prescription digital therapeutic for patients with major depressive disorder. The app, which changes users’ behavior through various lessons and exercises, was developed by Otsuka…
Continue Reading
What You Should Know:
· Yseop, a world-leading Artificial Intelligence (AI) software company and pioneer in Generative AI, has announced today the development of an enhanced Generative AI application tailored for the Biopharma industry, with…
Continue Reading
What You Should Know:
– Quest Diagnostics today announced it will acquire key assets of PathAI Diagnostics, including its state-of-the-art digital pathology laboratory in Memphis, Tennessee.
– As part of the acquisition, this facility will become…
Continue Reading
Season 2 of the MedCity Pivot Podcast has launched with a special focus on the evolution of phamacy and pharmacy benefit management. The first guest this season is A.J. Loiacono, who leads Capital Rx,…
Continue Reading
For more than 10 years, MedCity INVEST has brought together active investors and promising startups across biopharma, diagnostics, medical devices, and health tech. The conference content highlights opportunities and challenges in the healthcare industry…
Continue Reading
What You Should Know:
– PathAI, a leading force in AI-powered pathology, has joined forces with Google Cloud at the Bio-IT World Conference & Expo to accelerate the integration of AI and digital pathology workflows…
Continue Reading
Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific…
Continue Reading
